Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palbociclib and Ibrutinib in Previously Treated Mantle Cell Lymphoma
NCT03478514Phase 2Active, not recruiting
- Sponsor
- Alliance Foundation Trials
- Start
- Sep 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in mantle cell lymphoma (MCL), sponsored by Alliance Foundation Trials. Started Sep 2018; status: active, not recruiting.
02
Drugs
palbociclib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT03478514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478514.